https://www.selleckchem.com/pr....oducts/cloperastine-
We aimed to evaluate the impact of foveal eversion on treatment response and persistent diabetic macular edema (DME). The study was designed as interventional and prospective. DME eyes were treated with ranibizumab and/or dexamethasone (DEX) implants, or with fluocinolone acetonide (FAc) implants. FAc-treated eyes were eventually retreated by additional ranibizumab injections. Main outcome measure was the relationship between foveal eversion and both clinical outcome and persistent DME. Sixty-eight DME eyes (68 patients)
Like
Comment
Share
